All News

Click the title above to open the Pharmaceutical Executive August 2016 issue in an interactive PDF format.

July 22, 2016

Click the title above to open the Pharmaceutical Executive July 2016 issue in an interactive PDF format.

In the healthcare industry, “patient centricity” is like comfort food – everyone knows what it is, but it can mean very different things to different people.

In this paper, we’ll explore opportunities pharma marketers have to create engaging experiences that will deliver new types of value to meet their targets’ evolving expectations.

Policy makers "simply are not taking seriously the corrosive effect of corruption", study says.

Top officials at EMA push the boat out on drug-pricing views.

Policymakers seek to limit prescribing while also encouraging innovative R&D.

Click the title above to open the Pharmaceutical Executive May 2016 issue in an interactive PDF format.

How the DIA, a key industry NGO, is repositioning itself as the go-to place for the independent knowledge-driven insights that drive decisions in a business with no boundaries. One world. One table. Open seating.

Altruism and self-interest are at the heart of European thinking on neglected diseases.

The practice’s emerging-if improbable-cost-saving potential.

Click the title above to open the Pharmaceutical Executive April 2016 issue in an interactive PDF format.

Europe’s contrasting views on rare disease drugs - one bashing pricing abuses, the other extolling their public health virtues - could ultimately leave these products out in the cold.